logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Abercrombie, Ian
    Ceo born in June 1961
    Individual (3 offsprings)
    Officer
    icon of calendar 2022-02-02 ~ now
    OF - Director → CIF 0
  • 2
    Hanna, Wilfred Sydney
    Company Director born in April 1967
    Individual (17 offsprings)
    Officer
    icon of calendar 2019-10-01 ~ now
    OF - Director → CIF 0
  • 3
    NUCANA BIOPHARMACEUTICALS LIMITED - 2008-07-02
    NUCANA LIMITED - 2006-11-02
    DUNWILCO (1277) LIMITED - 2005-10-14
    icon of address1, Lochrin Square, 92-98 Fountainbridge, Edinburgh, Scotland
    Active Corporate (5 parents, 1 offspring)
    Equity (Company account)
    261,095 GBP2024-09-30
    Person with significant control
    icon of calendar 2019-10-01 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 1
  • Quinn, Martin Alexander
    Solicitor born in March 1970
    Individual (16 offsprings)
    Officer
    icon of calendar 2016-10-07 ~ 2019-10-01
    OF - Director → CIF 0
    Mr Martin Alexander Quinn
    Born in March 1970
    Individual (16 offsprings)
    Person with significant control
    icon of calendar 2016-10-07 ~ 2019-10-01
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

ATEN THERAPEUTICS LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Debtors
4,887 GBP2024-09-30
7,033 GBP2023-09-30
Cash at bank and in hand
433 GBP2024-09-30
27,376 GBP2023-09-30
Current Assets
5,320 GBP2024-09-30
34,409 GBP2023-09-30
Net Current Assets/Liabilities
-128,463 GBP2024-09-30
-145,651 GBP2023-09-30
Equity
Called up share capital
1 GBP2024-09-30
1 GBP2023-09-30
Retained earnings (accumulated losses)
-128,464 GBP2024-09-30
-145,652 GBP2023-09-30
Equity
-128,463 GBP2024-09-30
-145,651 GBP2023-09-30
Average Number of Employees
02023-10-01 ~ 2024-09-30
02022-10-01 ~ 2023-09-30
Trade Debtors/Trade Receivables
Current
1 GBP2024-09-30
0 GBP2023-09-30
Other Debtors
Amounts falling due within one year
4,886 GBP2024-09-30
7,033 GBP2023-09-30
Debtors
Current, Amounts falling due within one year
4,887 GBP2024-09-30
7,033 GBP2023-09-30
Trade Creditors/Trade Payables
Current
1,500 GBP2024-09-30
77,239 GBP2023-09-30
Amounts owed to group undertakings
Current
130,183 GBP2024-09-30
94,581 GBP2023-09-30
Other Creditors
Current
2,100 GBP2024-09-30
8,240 GBP2023-09-30
Creditors
Current
133,783 GBP2024-09-30
180,060 GBP2023-09-30

  • ATEN THERAPEUTICS LTD
    Info
    Registered number SC547221
    icon of address1 Lochrin Square, 92-98 Fountainbridge, Edinburgh EH3 9QA
    Private Limited Company incorporated on 2016-10-07 (9 years). The company status is Active.
    The last date of confirmation statement was made at 2024-10-16
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.